XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]    
Shares Available for Grant, Outstanding, Beginning balance 1,327,645  
Additional shares authorized 1,728,441  
Shares Available for Grant, Granted (1,353,300)  
Shares Available for Grant, Restricted stock units granted (298,150)  
Shares Available for Grant, Forfeited or cancelled 109,039  
Restricted stock units forfeited 33,225  
Shares Available for Grant, Outstanding, Ending balance 1,546,900 1,327,645
Vested and exercisable as of March 31, 2022 3,115,184  
Number of Options, Outstanding, Beginning balance 5,262,185  
Number of Options, Granted 1,353,300  
Shares Available for Grant, Restricted stock units granted 298,150  
Number of Options, Exercised (15,995)  
Number of Options, Forfeited or cancelled (109,039)  
Number of Options, Outstanding, Ending balance 6,490,451 5,262,185
Weighted-Average Exercise Price, Outstanding, Beginning balance $ 10.24  
Weighted-Average Exercise Price, Granted 5.17  
Weighted-Average Exercise Price, Exercised 8.98  
Weighted Average Exercise Price Per Option, Forfeited or cancelled 12.06  
Weighted-Average Exercise Price, Outstanding, Ending balance 9.16 $ 10.24
Weighted-Average Exercise Price, vested and exercisable $ 11.07  
Weighted Average Remaining Contractual Life, Ending balance 7 years 9 months 7 years 3 months
Vested and exercisable as of March 31, 2022 6 years 2 months 19 days  
Aggregate Intrinsic Value $ 7,636 $ 530
Aggregate Intrinsic Value, Vested and exercisable $ 1,934